| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |